Login / Signup

The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.

Jia-Yi HuangXue-Lian ChenXiao-Feng XieLin SongLi-Ping ChenXiao-Feng LanXue BaiXuelian ChenCai-Wen Du
Published in: Cancer medicine (2024)
Low-dose apatinib combined with oral vinorelbine demonstrates potential efficacy and well tolerated for pretreated HER2-negative mBC.
Keyphrases
  • low dose
  • metastatic breast cancer
  • high dose
  • phase ii study
  • randomized controlled trial
  • human health
  • study protocol
  • double blind